|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/423 | (2006.01) |
| A61K 31/423 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 9/19 | (2013.01) |
| (11) | Number of the document | 3733175 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18894766.7 |
| Date of filing the European patent application | 2018-08-01 | |
| (97) | Date of publication of the European application | 2020-11-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2018/028887 |
| Date | 2018-08-01 |
| (87) | Number | WO 2019/130637 |
| Date | 2019-07-04 |
| (30) | Number | Date | Country code |
| 2017253385 | 2017-12-28 | JP |
| (72) |
ENDOU Hitoshi , JP
FURUSE Junji , JP
OKAYASU Isao , JP
WEMPE Michael F. , US
|
| (73) |
J-Pharma Co., Ltd. ,
75-1 Onocho
Tsurumi-ku
Yokohama-shi, Kanagawa 230-0046,
JP
|
| (54) | CANCER THERAPEUTIC |
| CANCER THERAPEUTIC |